20160502 CCMG-CCGM - Trainee Poster Presentations - Session 1 - Odd Numbers

Interactive session with the authors of poster presentations.

TMG-201 disruption of CEP55 causes cytokinesis defects and MARCH syndrome
Dr. Heleen Arts, McMaster University

TMG-203 Severe rhizomelic shortening in a child with a complex duplication/deletion rearrangement of chromosome X.
Dr. Ashish Deshwar

TMG-205 Analysis of exome filtering techniques for the prioritization of clinically relevant genes
Dr. Kristin Kernohan

TMG-207 Characterization of 5 adult patients with m.15152G>A, a novel mutation in mitochondrial cytochrome b
Dr. Natascia Anastasio, McGill University

TMG-209 Diagnosing multiple genetic diseases in families by whole exome sequencing debunks Occam’s razor
Dr. Tugce Balci, Children's Hospital of Eastern Ontario, University of Ottawa

TMG-211 Improved diagnostic yield and comparable coverage to targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test in paediatric medicine
Dr. Christian R. Marshall, The Hospital for Sick Children

TMG-213 Clinical diagnosis of Duchenne Muscular Dystrophy in a case with an as-yet unidentified genetic cause
Dr. Michelle Axford, The Hospital for Sick Children

TMG-215 Vascular Ehlers-Danlos Syndrome in two families presenting with extensive bruising
Dr. Shuaa Basalom, McGill University

TMG-219 Ambulatory status and quality of life in children with Friedreich ataxia
Dr. Resham Ejaz, The Hospital for Sick Children

TMG-221 Tatton-Brown-Rahman Syndrome is a diagnostic consideration in individuals with Marfanoid features
Dr. James O'Byrne

TMG-223 Nutritional Deficiency Complicating the Diagnosis of an Inborn Error of Metabolism: a Case Study
Dr. Estrella Lizabeth Mellin-Sanchez

Question Title

* 1. Please Rate Each Session:

	Did Not Attend	Poor	Fair	Good	Very Good	Excellent
TMG-201 disruption of CEP55 causes cytokinesis defects and MARCH syndrome	TMG-201 disruption of CEP55 causes cytokinesis defects and MARCH syndrome Did Not Attend	TMG-201 disruption of CEP55 causes cytokinesis defects and MARCH syndrome Poor	TMG-201 disruption of CEP55 causes cytokinesis defects and MARCH syndrome Fair	TMG-201 disruption of CEP55 causes cytokinesis defects and MARCH syndrome Good	TMG-201 disruption of CEP55 causes cytokinesis defects and MARCH syndrome Very Good	TMG-201 disruption of CEP55 causes cytokinesis defects and MARCH syndrome Excellent
TMG-203 Severe rhizomelic shortening in a child with a complex duplication/deletion rearrangement of chromosome X.	TMG-203 Severe rhizomelic shortening in a child with a complex duplication/deletion rearrangement of chromosome X. Did Not Attend	TMG-203 Severe rhizomelic shortening in a child with a complex duplication/deletion rearrangement of chromosome X. Poor	TMG-203 Severe rhizomelic shortening in a child with a complex duplication/deletion rearrangement of chromosome X. Fair	TMG-203 Severe rhizomelic shortening in a child with a complex duplication/deletion rearrangement of chromosome X. Good	TMG-203 Severe rhizomelic shortening in a child with a complex duplication/deletion rearrangement of chromosome X. Very Good	TMG-203 Severe rhizomelic shortening in a child with a complex duplication/deletion rearrangement of chromosome X. Excellent
TMG-205 Analysis of exome filtering techniques for the prioritization of clinically relevant genes	TMG-205 Analysis of exome filtering techniques for the prioritization of clinically relevant genes Did Not Attend	TMG-205 Analysis of exome filtering techniques for the prioritization of clinically relevant genes Poor	TMG-205 Analysis of exome filtering techniques for the prioritization of clinically relevant genes Fair	TMG-205 Analysis of exome filtering techniques for the prioritization of clinically relevant genes Good	TMG-205 Analysis of exome filtering techniques for the prioritization of clinically relevant genes Very Good	TMG-205 Analysis of exome filtering techniques for the prioritization of clinically relevant genes Excellent
TMG-207 Characterization of 5 adult patients with m.15152G>A, a novel mutation in mitochondrial cytochrome b	TMG-207 Characterization of 5 adult patients with m.15152G>A, a novel mutation in mitochondrial cytochrome b Did Not Attend	TMG-207 Characterization of 5 adult patients with m.15152G>A, a novel mutation in mitochondrial cytochrome b Poor	TMG-207 Characterization of 5 adult patients with m.15152G>A, a novel mutation in mitochondrial cytochrome b Fair	TMG-207 Characterization of 5 adult patients with m.15152G>A, a novel mutation in mitochondrial cytochrome b Good	TMG-207 Characterization of 5 adult patients with m.15152G>A, a novel mutation in mitochondrial cytochrome b Very Good	TMG-207 Characterization of 5 adult patients with m.15152G>A, a novel mutation in mitochondrial cytochrome b Excellent
TMG-209 Diagnosing multiple genetic diseases in families by whole exome sequencing debunks Occam’s razor	TMG-209 Diagnosing multiple genetic diseases in families by whole exome sequencing debunks Occam’s razor Did Not Attend	TMG-209 Diagnosing multiple genetic diseases in families by whole exome sequencing debunks Occam’s razor Poor	TMG-209 Diagnosing multiple genetic diseases in families by whole exome sequencing debunks Occam’s razor Fair	TMG-209 Diagnosing multiple genetic diseases in families by whole exome sequencing debunks Occam’s razor Good	TMG-209 Diagnosing multiple genetic diseases in families by whole exome sequencing debunks Occam’s razor Very Good	TMG-209 Diagnosing multiple genetic diseases in families by whole exome sequencing debunks Occam’s razor Excellent
TMG-211 Improved diagnostic yield and comparable coverage to targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test in paediatric medicine	TMG-211 Improved diagnostic yield and comparable coverage to targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test in paediatric medicine Did Not Attend	TMG-211 Improved diagnostic yield and comparable coverage to targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test in paediatric medicine Poor	TMG-211 Improved diagnostic yield and comparable coverage to targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test in paediatric medicine Fair	TMG-211 Improved diagnostic yield and comparable coverage to targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test in paediatric medicine Good	TMG-211 Improved diagnostic yield and comparable coverage to targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test in paediatric medicine Very Good	TMG-211 Improved diagnostic yield and comparable coverage to targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test in paediatric medicine Excellent
TMG-213 Clinical diagnosis of Duchenne Muscular Dystrophy in a case with an as-yet unidentified genetic cause	TMG-213 Clinical diagnosis of Duchenne Muscular Dystrophy in a case with an as-yet unidentified genetic cause Did Not Attend	TMG-213 Clinical diagnosis of Duchenne Muscular Dystrophy in a case with an as-yet unidentified genetic cause Poor	TMG-213 Clinical diagnosis of Duchenne Muscular Dystrophy in a case with an as-yet unidentified genetic cause Fair	TMG-213 Clinical diagnosis of Duchenne Muscular Dystrophy in a case with an as-yet unidentified genetic cause Good	TMG-213 Clinical diagnosis of Duchenne Muscular Dystrophy in a case with an as-yet unidentified genetic cause Very Good	TMG-213 Clinical diagnosis of Duchenne Muscular Dystrophy in a case with an as-yet unidentified genetic cause Excellent
TMG-215 Vascular Ehlers-Danlos Syndrome in two families presenting with extensive bruising	TMG-215 Vascular Ehlers-Danlos Syndrome in two families presenting with extensive bruising Did Not Attend	TMG-215 Vascular Ehlers-Danlos Syndrome in two families presenting with extensive bruising Poor	TMG-215 Vascular Ehlers-Danlos Syndrome in two families presenting with extensive bruising Fair	TMG-215 Vascular Ehlers-Danlos Syndrome in two families presenting with extensive bruising Good	TMG-215 Vascular Ehlers-Danlos Syndrome in two families presenting with extensive bruising Very Good	TMG-215 Vascular Ehlers-Danlos Syndrome in two families presenting with extensive bruising Excellent
TMG-219 Ambulatory status and quality of life in children with Friedreich ataxia	TMG-219 Ambulatory status and quality of life in children with Friedreich ataxia Did Not Attend	TMG-219 Ambulatory status and quality of life in children with Friedreich ataxia Poor	TMG-219 Ambulatory status and quality of life in children with Friedreich ataxia Fair	TMG-219 Ambulatory status and quality of life in children with Friedreich ataxia Good	TMG-219 Ambulatory status and quality of life in children with Friedreich ataxia Very Good	TMG-219 Ambulatory status and quality of life in children with Friedreich ataxia Excellent
TMG-221 Tatton-Brown-Rahman Syndrome is a diagnostic consideration in individuals with Marfanoid features	TMG-221 Tatton-Brown-Rahman Syndrome is a diagnostic consideration in individuals with Marfanoid features Did Not Attend	TMG-221 Tatton-Brown-Rahman Syndrome is a diagnostic consideration in individuals with Marfanoid features Poor	TMG-221 Tatton-Brown-Rahman Syndrome is a diagnostic consideration in individuals with Marfanoid features Fair	TMG-221 Tatton-Brown-Rahman Syndrome is a diagnostic consideration in individuals with Marfanoid features Good	TMG-221 Tatton-Brown-Rahman Syndrome is a diagnostic consideration in individuals with Marfanoid features Very Good	TMG-221 Tatton-Brown-Rahman Syndrome is a diagnostic consideration in individuals with Marfanoid features Excellent
TMG-223 Nutritional Deficiency Complicating the Diagnosis of an Inborn Error of Metabolism: a Case Study	TMG-223 Nutritional Deficiency Complicating the Diagnosis of an Inborn Error of Metabolism: a Case Study Did Not Attend	TMG-223 Nutritional Deficiency Complicating the Diagnosis of an Inborn Error of Metabolism: a Case Study Poor	TMG-223 Nutritional Deficiency Complicating the Diagnosis of an Inborn Error of Metabolism: a Case Study Fair	TMG-223 Nutritional Deficiency Complicating the Diagnosis of an Inborn Error of Metabolism: a Case Study Good	TMG-223 Nutritional Deficiency Complicating the Diagnosis of an Inborn Error of Metabolism: a Case Study Very Good	TMG-223 Nutritional Deficiency Complicating the Diagnosis of an Inborn Error of Metabolism: a Case Study Excellent

Question Title

* 2. Please assess the Sessions as a whole

	Strongly Disagree	Disagree	Neutral	Agree	Strongly Agree
Sufficient time was allowed for audience participation/active learning	Sufficient time was allowed for audience participation/active learning Strongly Disagree	Sufficient time was allowed for audience participation/active learning Disagree	Sufficient time was allowed for audience participation/active learning Neutral	Sufficient time was allowed for audience participation/active learning Agree	Sufficient time was allowed for audience participation/active learning Strongly Agree
The facilities were satisfactory	The facilities were satisfactory Strongly Disagree	The facilities were satisfactory Disagree	The facilities were satisfactory Neutral	The facilities were satisfactory Agree	The facilities were satisfactory Strongly Agree
The session was free from commercial bias	The session was free from commercial bias Strongly Disagree	The session was free from commercial bias Disagree	The session was free from commercial bias Neutral	The session was free from commercial bias Agree	The session was free from commercial bias Strongly Agree
Overall, I would rate this Symposium as excellent	Overall, I would rate this Symposium as excellent Strongly Disagree	Overall, I would rate this Symposium as excellent Disagree	Overall, I would rate this Symposium as excellent Neutral	Overall, I would rate this Symposium as excellent Agree	Overall, I would rate this Symposium as excellent Strongly Agree

Question Title

* 3. As a result of attending these sessions, I am planning to:

a) Discuss the session with my colleagues

b) Pursue additional learning activities.

c) Complete a Personal Learning Project.

d) Not change my practice.

e) Change my practice.

Question Title

* 4. Please explain any changes you plan to make or personal learning projects you will pursue as a result of this session:

Question Title

* 5. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply)

Medical Expert

Communicator

Collaborator

Manager

Health Advocate

Scholar

Professional

20160502 CCMG-CCGM - Trainee Poster Presentations - Session 1 - Odd Numbers

Interactive session with the authors of poster presentations.

Question Title

* 1. Please Rate Each Session:

Question Title

* 2. Please assess the Sessions as a whole

Question Title

* 3. As a result of attending these sessions, I am planning to:

Question Title

* 4. Please explain any changes you plan to make or personal learning projects you will pursue as a result of this session:

Question Title

* 5. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply)

Question Title

* 6. General comments about individual speakers:

Question Title

* 7. What topics would you like to be addressed at future conferences to keep you up to date in your profession?